Best Dermatology Companies in Israel
The 54 best Dermatology companies in Israel in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: Lumenis.
- Dermatology Market Size Worth USD 2.04 Billion in 2030
Ranked: Best Dermatology companies in Israel
| # | Company | Disclosed funding | Last round | Stage | Founder | Founded | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Lumenis Minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets | $214M | 204 mo ago | Acquired | Tzipi Ozer-Armon Chief Executive Officer | 1973 | WordPressApple iCloud MailMicrosoft 365+41 | 778 patents Medical laser and fiber-optic devices for aesthetic, therapeutic, and diagnostic procedures | 1 partnership |
| 2 | Foamix Developer of proprietary dermatology therapuetics | $66M | 83 mo ago | Public | Meir Eini Founder | 2001 | — | 284 patents Pharmaceutical and cosmetic foamed delivery systems for topical antibiotics and rheology control | — |
| 3 | Lutris Pharma Provider of anti-cancer therapy 29Patents top 32%Moat top 32%Funding top 33%Talent top 33% All 9 signals ▾Patentstop 32% Moattop 32% Fundingtop 33% Talenttop 33% Innovationtop 38% Globalbottom 40% Techbottom 31% Newsbottom 18% Marketbottom 17% Patents: 75 patents matched (strict assignee match) · 41 filings since 2022 vs 34 in 2017-21 Moat: Editorial + unicorn rating 4/10 · IP moat: 75 patents rank vs industry peers · Fliar Intelligence Index 29/100 | $30M | 17 mo ago | Series B | Antoni Ribas Founder & Chairman | 2016 | WordPressMySQLPHP+12 | 75 patents Topical BRAF‑kinase inhibitors for EGFR‑related skin reactions and radiation dermatitis; isoquinoline wound‑healing agents. | — |
| 4 | Collplant Developer of recombinant human collagen for regenerative medicine and aesthetics 53Patents top 22%Funding top 26%Product top 26%Tech top 35% All 10 signals ▾Patentstop 22% Fundingtop 26% Producttop 26% Techtop 35% Moattop 35% Innovationtop 43% Newstop 47% Growthbottom 47% Marketbottom 46% Globalbottom 43% Patents: 170 patents matched (strict assignee match) · 41 filings since 2022 vs 46 in 2017-21 Funding: Raised $16.3M across 11 rounds · 11 rounds over 20 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $16M | 5 mo ago | Public | — | 2004 | WordPressMySQLPHP+21 | 169 patents Collagen-based biomaterials for soft‑tissue fillers, implants, and 3D‑printed regenerative devices | — |
| 5 | Kamari Pharma Developer of therapies for rare dermatologic diseases and itch conditions 22Moat top 32%Patents top 36%Innovation top 42%Funding top 46% All 6 signals ▾Moattop 32% Patentstop 36% Innovationtop 42% Fundingtop 46% Globalbottom 40% Marketbottom 23% Moat: Editorial + unicorn rating 4/10 · IP moat: 28 patents Patents: 28 patents matched (strict assignee match) · 26 filings since 2022 vs 2 in 2017-21 rank vs industry peers · Fliar Intelligence Index 22/100 | $8M | 13 mo ago | Series A | — | 2018 | — | 28 patents Small-molecule therapeutics for treating dermatological skin disorders and related symptoms. | — |
| 6 | OWC Pharmaceutical Research Developer of cannabis-based therapeutics for multiple ailments | $5M | 98 mo ago | Public | Zvi Riterband CEO | 2008 | — | — | — |
| 7 | DermiPsor Combination topical drug for psoriasis | $3M | 216 mo ago | Acqui-Hired | Zeev Even-Chen CEO | 2004 | — | 47 patents Topical dermatology formulations combining calcipotriol, nicotinamide, and PEG carriers for hyperproliferative skin conditions. | — |
| 8 | PerfAction Developing nonsurgical face lifting, skin regeneration and scar repair treatments | $2M | 190 mo ago | Seed | — | 2007 | — | — | — |
| 9 | Hairstetics Multiple hair implantation device | $2M | 169 mo ago | Seed | Boaz Shenhav Co-Founder & CEO | 2010 | — | 25 patents Hair implantation anchors and devices for surgical hair restoration procedures. | — |
| 10 | Juvenis Developer of biopolymers for tissue augmentation & reconstruction | $1M | 172 mo ago | Seed | Lior Yankelson Co-Founder | 2007 | — | 9 patents Biodegradable polymer gel systems for soft tissue repair and augmentation | — |
| 11 | Polyol Biotech Developer of PFA-based cream for reducing ultraviolet radiation damage to the skin | $445K | 214 mo ago | Deadpooled | Shai Meretzki Founder & Partner | 2007 | — | 9 patents Natural polyhydroxylated fatty alcohols from avocado seed for cosmetic and pharmaceutical use | — |
| 12 | TavTech Jet technology for aesthetic & medical applications | $200K | 310 mo ago | Early Stage | Izhak Yaniv CEO | 1996 | WordPressMySQLPHP+20 | 33 patents High‑velocity jet spray devices for transdermal drug and skin‑treatment delivery | 4 launchs |
Top 12 Dermatology companies in Israel
#1
Public · Ness Ziona, Center District · founded 2004 · 73 employees$16.3Mraised▾
Developer of recombinant human collagen for regenerative medicine and aesthetics. It focuses on creating technologies and products for tissue regeneration and organ manufacturing. The company's plant-based technology enables the production of recombinant human type I collagen. This collagen is identical to that produced by the human body. The company develops products aimed at bioprinting tissues and organs and medical aesthetics.
- Feb 2026Post IPO$4M
- Feb 2020Post IPO$4.5M
- Sep 2019Post IPO$5.5M
- Nov 2017Post IPO$2M
#2
Series B · Tel Aviv, Tel Aviv · founded 2016 · 4 employees$30Mraised▾
Lutris Pharma is developing anticancer therapy based on EGFR (Epidermal Growth Factor Receptor) Inhibitors. It helps in reducing dose-limiting side effects mainly dermal toxicity. It develops its proprietary small molecule B-Raf-based inhibitor LUT014, reducing acneiform lesions. It is in phase 1 clinical trial.
- Jan 2025Series B$30M
#3
Series A · Ness Ziona, Center District · founded 2018 · 7 employees$8Mraised▾
Developer of therapies for rare dermatologic diseases and itch conditions. It offers topical and oral TRPV3 inhibitors treatment of Lichen simplex chronicus related itch, Palmoplantar Keratoderma, and Ichthyosis.
- Jun 2025Series A$23M
- Sep 2022Series A$8M
#4
Acquired · Yokneam Illit, Northern District · founded 1973 · 102 employees$214Mraised▾
Lumenis develops minimally-invasive clinical solutions for the Surgical, Ophthalmology and Aesthetic markets. In surgical segment their offering includes products for urology, ENT, gynecology and gastroenterology. In aesthetic segment their offering includes hair removal and skin treatments products. In opthalmology segment their offering includes products for glaucoma, retinal diseases. They have presence in over 100 countries. Lumenis was acquired by Viola Group and Ofer Hi-Tech in 2006. XIO acquired Lumenis for $510M in 2015.
#5
Public · Rehovot, Central District · founded 2001 · 81 employees$66Mraised▾
Foamix Pharmaceuticals is developing proprietary dermatology therapeutics. The company has the lead candidates: FMX101, a minocycline foam for moderate-to-severe acne in Phase III clinical trials and FMX 103 for rosacea with Phase III in progress. The company has developed a topical foam formulation for its candidates.
- Jul 2019Conventional Debt$50M
- Apr 2018Post IPO$16M
#6
Public · Petah Tikva, Central District · founded 2008$5Mraised▾
Developer of cannabis-based therapeutics for multiple ailments. The company is developing topical creams and sublingual disintegrating tablets for several medical conditions, like multiple myeloma, psoriasis, fibromyalgia, PTSD (post-traumatic stress disorder), and migraines.
- May 2018Post IPO$5M
#7
Acqui-Hired · Tel Aviv, Tel Aviv · founded 2004$3Mraised▾
DermiPsor was a clinical stage drug development company focused on drugs for the dermatology market. Its lead product called DPS-101 was a combination therapeutics that target multiple physiological pathways. The product has applications as a non-steroidal topical treatment for mild to moderate psoriasis. As of December 2016, the candidate has completed the phase 2b feasibility study and is planning for phase 2/3 clinical trials. In 2013, Nextgen Biomed entered into a reverse merger with DermiPsor & has acquired 98.6% of its stake.
- Jun 2008Series A$1.8M
- Jun 2008Convertible Debt$615K
- Feb 2007Seed$590.5K
#8
Seed · Rehovot, Central District · founded 2007 · 15 employees$2.2Mraised▾
PerfAction is focussed on developing a non-surgical dermal remodeling treatment that combines kinetic energy with an active compound such as hyaluronic acid (HA) for dermal remodeling and superior clinical results. Based on its proprietary Jet Volumetric Remodeling (JVR) technology, it has developed its flagship product EnerJet, a dermal remodeling system that pneumatically introduces a jet of HA for face-lifting, repair scars and regenerate skin.
- Sep 2010Seed$1.5M
- Jul 2010Seed—
- 2009Venture Debt$240K
- Jun 2008Seed$660K
#9
Seed · Netanya, Central District · founded 2010 · 12 employees$1.5Mraised▾
Developer of multiple-hair implantation device intended to help people with hair fall problems. The company's product aims to simplify the implantation procedure, shorten recovery time and provide superior aesthetic results at a lower cost than traditional methods, enabling customers with innovative hair loss treatment options.
#10
Seed · Misgav, Northern District · founded 2007$1Mraised▾
Developer of biopolymers for tissue augmentation & reconstruction. It has developed an injectable, biodegradable polymer that forms a soft, gel when injected into the tissue and degrades slowly over time into safe components that are naturally eliminated from the body. Its first line of products called Tenergel claims to have applications in aesthetic and related reconstructive fat replacement.
- Mar 2012Seed$1M
#11
Deadpooled · Haifa, Haifa District · founded 2007$444.8Kraised▾
Polyol Biotech is focussed on developing natural topical solutions for the dermatology market. Its technology is based on patented Avocare PFA (Polyhydroxylated Fatted Alcohols) compound isolated from avocado seeds that have demonstrated its efficacy in cosmetics and skin treatment. Using this technology, it is developing its first product which is a cream for reducing ultraviolet radiation damage to the skin.
- Sep 2008Seed$444.8K
#12
Early Stage · Yehud, Center District · founded 1996 · 21 employees$200Kraised▾
Manufacturer of medical and aesthetic applications focused on proprietary technology based on a water jet. The company patented technology creates a two-phase jet of accelerated microdroplets consisting of air and medical gas, providing a versatile and precise means of performing a wide variety of skin treatments.
Funding & investor landscape
Notable founders
Market landscape — 10 sub-themes by coverage
Share of Dermatology coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
Common questions
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.